Literature DB >> 25520063

Age of diagnosis of breast cancer in china: almost 10 years earlier than in the United States and the European union.

Qing-Kun Song1, Jing Li, Rong Huang, Jin-Hu Fan, Rong-Shou Zheng, Bao-Ning Zhang, Bin Zhang, Zhong-Hua Tang, Xiao-Ming Xie, Hong-Jian Yang, Jian-Jun He, Hui Li, Jia-Yuan Li, You-Lin Qiao, Wan-Qing Chen.   

Abstract

BACKGROUND: The study aimed to describe the age distribution of breast cancer diagnosis among Chinese females for comparison with the United States and the European Union, and provide evidence for the screening target population in China.
MATERIALS AND METHODS: Median age was estimated from hospital databases from 7 tertiary hospitals in China. Population-based data in China, United States and European Union was extracted from the National Central Cancer Registry, SEER program and GLOBOCAN 2008, respectively. Age-standardized distribution of breast cancer at diagnosis in the 3 areas was estimated based on the World Standard Population 2000.
RESULTS: The median age of breast cancer at diagnosis was around 50 in China, nearly 10 years earlier than United States and European Union. The diagnosis age in China did not vary between subgroups of calendar year, region and pathological characteristics. With adjustment for population structure, median age of breast cancer at diagnosis was 50~54 in China, but 55~59 in United States and European Union.
CONCLUSIONS: The median diagnosis age of female breast cancer is much earlier in China than in the United States and the European Union pointing to racial differences in genetics and lifestyle. Screening programs should start at an earlier age for Chinese women and age disparities between Chinese and Western women warrant further studies.

Entities:  

Mesh:

Year:  2014        PMID: 25520063     DOI: 10.7314/apjcp.2014.15.22.10021

Source DB:  PubMed          Journal:  Asian Pac J Cancer Prev        ISSN: 1513-7368


  25 in total

1.  A novel recurrent CHEK2 Y390C mutation identified in high-risk Chinese breast cancer patients impairs its activity and is associated with increased breast cancer risk.

Authors:  N Wang; H Ding; C Liu; X Li; L Wei; J Yu; M Liu; M Ying; W Gao; H Jiang; Y Wang
Journal:  Oncogene       Date:  2015-01-26       Impact factor: 9.867

2.  Symptom burden in advanced breast cancer patients and its association between death anxiety and psychological distress.

Authors:  Zhongge Su; Yuhe Zhou; Xinkun Han; Ying Pang; Shuangzhi He; Lili Tang
Journal:  Chin J Cancer Res       Date:  2022-06-30       Impact factor: 4.026

3.  Trends of cancer mortality in Xi'an City, China: 2005-2020.

Authors:  Ning Chen; Xiao-Yu Zhang; Lin-Lin Ma; Guo-Dong Zhao; Yu-Xiang Yan
Journal:  J Cancer Res Clin Oncol       Date:  2022-05-14       Impact factor: 4.322

4.  68Ga-NOTA-RM26 PET/CT in the Evaluation of Breast Cancer: A Pilot Prospective Study.

Authors:  Jie Zang; Feng Mao; Hao Wang; Jingjing Zhang; Qingxing Liu; Li Peng; Fang Li; Lixin Lang; Xiaoyuan Chen; Zhaohui Zhu
Journal:  Clin Nucl Med       Date:  2018-09       Impact factor: 7.794

5.  SNHG1 Long Noncoding RNA is Potentially Up-Regulated in Colorectal Adenocarcinoma.

Authors:  Niloofar Avazpour; Mohamadreza Hajjari; Seyed Reza Kazemi Nezhad; Maryam Tahmasebi Birgani
Journal:  Asian Pac J Cancer Prev       Date:  2020-04-01

6.  A Technique of Endoscopic Nipple-Sparing Mastectomy for Breast Cancer.

Authors:  Yu Wang; Ji-Xiang Wu; Shan Guan
Journal:  JSLS       Date:  2017 Apr-Jun       Impact factor: 2.172

7.  Modification effects of genetic polymorphisms in FTO, IL-6, and HSPD1 on the associations of diabetes with breast cancer risk and survival.

Authors:  Rui-Mei Zhu; Wei Lin; Wei Zhang; Jun-Ting Ren; Yi Su; Jian-Rong He; Ying Lin; Feng-Xi Su; Xiao-Ming Xie; Lu-Ying Tang; Ze-Fang Ren
Journal:  PLoS One       Date:  2017-06-07       Impact factor: 3.240

8.  Assessment of myocardial extracellular volume on body computed tomography in breast cancer patients treated with anthracyclines.

Authors:  Caterina Beatrice Monti; Moreno Zanardo; Tommaso Bosetti; Marco Alì; Elena De Benedictis; Alberto Luporini; Francesco Secchi; Francesco Sardanelli
Journal:  Quant Imaging Med Surg       Date:  2020-05

9.  Estimation of cancer burden in Guangdong Province, China in 2009.

Authors:  Su-Mei Cao; Yan-Jun Xu; Guo-Zhen Lin; Qi-Hong Huang; Kuang-Rong Wei; Shang-Hang Xie; Qing Liu
Journal:  Chin J Cancer       Date:  2015-11-16

10.  Bioinformatics-based identification of miR-542-5p as a predictive biomarker in breast cancer therapy.

Authors:  Qiong-Ni Zhu; Helen Renaud; Ying Guo
Journal:  Hereditas       Date:  2018-01-15       Impact factor: 3.271

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.